Insider Tracker SEC Form 4 insider trades
← All clusters
QNRX

Quoin Pharmaceuticals Ltd.

AI summary Insiders participate in a private placement financing of up to $50.0 million.

56
Insider Score Band below 60
Research score
67
AI adjustment
-11

Research score, not a recommendation.

Total bought$280.0K4 Form 4 purchases
Distinct insiders4open-market buyers
Lead insiderMyers MichaelCEO
Cluster window2026-08-31single day · active

Market data

Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.

–

same price, one day All 4 purchases were at $4.88 on 2026-08-31. That pattern also occurs in IPO or conversion subscriptions, which are not open-market conviction buying.

Why this score

Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.

Breadth number & diversity of participating insiders
63%
Seniority executive rank of buyers (CEO/CFO/Director)
95%
Commitment purchase size relative to company & holdings
76%
Context buying into stock weakness signals conviction
100%
Timing coordinated purchases within a tight window
100%
Routine-purchase discount × 1.00
Company-type / offering discount × 0.50
Net insider selling penalty − 0

Why are they buying?

AI · ipo_offering · catalyst credible · documented

The insiders bought shares as part of a newly announced private placement financing of up to $50.0 million to fund general corporate purposes and clinical development.

On August 28, 2026, Quoin Pharmaceuticals announced a securities purchase agreement with institutional investors and members of management and the Board of Directors to issue ADSs and accompanying ordinary warrants at a combined purchase price of $4.88 per ADS.

Stock Price & Insider Purchase History

Daily close price with open-market insider purchases plotted over time

Loading price history…

Transactions

4 Form 4 trades · 4 insiders Sign in to download CSV
Purchases in this cluster, grouped by insider, largest first
Date Insider Role Shares Price Value Flags Filing
2026-08-31 Myers Michael history of Myers Michael's purchases CEO 20,490 $4.88 $100.0K
offering
SEC filing for Myers Michael (opens in a new tab)
2026-08-31 Carter Denise P. history of Carter Denise P.'s purchases COO 20,490 $4.88 $100.0K
offering
SEC filing for Carter Denise P. (opens in a new tab)
2026-08-31 Lawlor Sally Bridget history of Lawlor Sally Bridget's purchases CFO 10,244 $4.88 $50.0K
offering
SEC filing for Lawlor Sally Bridget (opens in a new tab)
2026-08-31 Culverwell Anthony James history of Culverwell Anthony James's purchases Director 6,146 $4.88 $30.0K
offering
SEC filing for Culverwell Anthony James (opens in a new tab)
Total $280.0K

Other buying runs at QNRX

A run ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

After this run became a cluster: 21 days -28.0%63 days –126 days –

Other insider buying runs at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days63 days126 days Status
2024-12-23 4 $600.0K 73 -49.8%-50.1%-67.3% closed
2024-09-03 → 2024-09-10 3 $81.1K 63 -26.0%+6.9%-56.6% closed